T3 augmentation of SSRI resistant depression

Journal of Affective Disorders

Volumn 91, Issue 2-3, 2006, Pages 211-215

  Abraham, Gebrehiwot ^a,b   Milev, Roumen ^c,d   Stuart Lawson, J ^d  

^a UNIVERSITY OF TORONTO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^c QUEEN S UNIVERSITY   (Canada)

^d Providence Continuing Care Centre   (Canada)

Author keywords

Augmentation; Resistant depression; SSRI; T3

Indexed keywords

CITALOPRAM; FLUVOXAMINE; LIOTHYRONINE; OLANZAPINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC TEST; DRUG POTENTIATION; DRUG TOLERABILITY; FEMALE; HAMILTON SCALE; HUMAN; INFORMED CONSENT; MAJOR DEPRESSION; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROTIRELIN TEST; REMISSION; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; THYROTROPIN BLOOD LEVEL; TREATMENT FAILURE; TREATMENT WITHDRAWAL; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE; FEMALE; FLUVOXAMINE; HUMANS; MALE; MIDDLE AGED; PAROXETINE; SEROTONIN UPTAKE INHIBITORS; SEVERITY OF ILLNESS INDEX; TRIIODOTHYRONINE;

EID: 33644998292     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jad.2006.01.013     Document Type: Article

References (32)

1. B. Appelhof, J. Brouwer, R. Dyck, E. Fliers, W. Hoogendijk, A. Huyser, J. Tijssen, and W. Wiersinga Triiodothyronine Addition to Paroxetine in the Treatment of Major Depressive Disorder vol. 89 2004 6271 6276
2. O. Agid, and B. Lere Algorithm-based treatment of major depression in an outpatient clinic: clinical correlates of response to a specific serotonin re-uptake inhibitor and to triiodothyronine augmentation Int. J. Neuropsychopharmacol. 6 2003 41 49
3. American Psychiatric Association Practice guideline for the treatment of patients with major depressive disorders (revision) Am. J. Psychiatry 157 1 2000 1 45
4. R. Aronson, H. Offman, R. Joffe, and C. Naylor Triiodothyronine augmentation in treatment of refractory depression Arch. Gen. Psychiatry 53 1996 842 848
5. T. Birkenhager, M. Vegt, and W. Nolen An open study of triiodothyronine augmentation of tricyclic antidepressants in patients with refractory depression Pharmacopsychiatry 30 1997 23 26
6. D. Crow, J. Collins, and R. Rosse Thyroid hormone supplementation of fluoxetine J. Clin. Psychopharmacol. 10 1990 150 151
7. L. Degroot Endocrinology 2nd ed. 1989 W.B. Saunders Philadelphia, PA
8. M. Gitlin, H. Weiner, L. Fairbanks, J. Hershman, and N. Freidfeld Failure of triiodothyronine to potentiate tricyclic antidepressant response J. Affect Disord. 13 1987 267 272
9. F. Goodwin, A. Prange, R. Post, G. Muscettola, and M. Lipton Potentiation of antidepressant effect by l-triiodothyronine in tricyclic non-responders Am. J. Psychiatry 139 1982 34 48
10. S. Gupta, P. Masand, and J. Tanquary Thyroid hormone supplementation of fluoxetine in the treatment of major depression Brit. J. Psychiatry 159 1991 866 867
11. M. Hamilton A rating scale for depression J. Neurol. Neurosurg. Psychiatry 23 1960 56 62
12. R. Hirschfeld, S. Montgomery, E. Aguglia, M. Amore, P. Delgado, M. Gastpar, C. Hawley, S. Kasper, M. Linden, J. Massana, J. Mendelewicz, H. Moller, C. Nemeroff, P. Such, R. Torta, and M. Versiani Partial response to antidepressant therapy: current approaches and treatment options J. Clin. Psychiatry 63 2002 826 837
13. D. Iosifescu, A. Nierenberg, D. Mischoulon, R. Perlis, G. Papakostas, J. Ryan, J. Alpert, and M. Fava An Open Study of Triiodothyronon Augumentation of Selective Serotonin Reuptake Inhibitors in Treatment-Resistant Major Depressive Disorder vol. 66 2005 1038 1042
14. R. Joffe Triiodothyronine potentiation of fluoxetine in depressed patients Can. J. Psychiatry 37 1992 48 49
15. R. Joffe, W. Singer, A. Levitt, and C. MacDonald A placebo-controlled comparison of lithium and triiodothyronine augmentation of tricyclic antidepressants in unipolar refractory depression Arch. Gen. Psychiatry 50 1993 387 393
16. G. Klee, and I. Hay Assessment of sensitive thyrotropin assays for an expanded role in thyroid function test: proposed criteria for analytic performance and clinical utility J. Clin. Endocrinol. Metab. 64 1987 461 471
17. D. Mischoulon, A. Nierenberg, L. Kizilbash, J. Rosenbaum, and M. Fava Strategies of managing depression refractory of SSRI treatment: a survey of clinicians Can. J. Psychiatry 45 2000 476 481
18. X. Moreau, R. Jeanningros, and P. Majjola-Pomietto Chronic effects of triiodothyronine in combination with imipramine on 5-HT transporter, 5-HT(1A) and 5-HT (2A) receptors in adult rat brain Neuropsychopharmacology 24 2001 652 662
19. J. Nelson Treatment of antidepressant non-responders: augmentation or switch? J. Clin. Psychiatry 59 Suppl 15 1998 35 41
20. M. Newman, O. Agid, E. Gur, and B. Lerer Pharmacological mechanisms of T3 augmentation of antidepressant action Int. J. Neuropsychopharmacol. 3 2003 187 191
21. A. Nierenberg, A. Farabaugh, and J. Alpert Timing of onset of antidepressant response with fluoxetine treatment Am. J. Psychiatry 157 2000 1423 1428
22. R. Prien, and J. Levine Research and methodological issues for evaluating the therapeutic effectiveness of antidepressant drugs Psychopharmacol. Bull. 20 1984 250 257
23. F. Quitkin, P. McGrath, and J. Stewart Chronological milestones to guide drug change: when should physicians switch antidepressants? Arch. Gen. Psychiatry 53 1996 785 792
24. G. Redmond Thyroid dysfunction and women's reproductive health Thyroid 14 2004 S5 S15 (suppl)
25. R. Shelton The use of antidepressants in novel combination therapies J. Clin. Psychiatry 64 2 2003 14 18
26. R. Shelton, G. Tollefson, and S. Stahl A novel augmentation strategy for treating resistant major depression Am. J. Psychiatry 158 2001 131 134
27. A. Souche, P. Baumann, L. Koeb, P. Thermos, J. Azorin, and H. Dufour Treatment of depression by a combination of clomipramine and triiodothyronine Encephale 17 1991 37 42
28. H. Stassen, A. Delini-Stula, and J. Angst Time course of improvement under antidepressant treatment: a survival analytical approach Eur. Neuropsychopharmacol. 3 1993 127 135
29. S. Targum, R. Greenberg, R. Harmon, K. Kessler, A. Salerian, and D. Fram Thyroid hormone and the TRH stimulation test in refractory depression J. Clin. Psychiatry 45 1984 345 346
30. M.E. Thase, and A.J. Rush When at first you don't succeed: sequential strategies for antidepressant nonresponders J. Clin. Psychiatry 58 suppl 13 1997 23 29
31. M. Thase, D. Kupfer, and D. Jarret Treatment of imipramine resistant recurrent depression: an open trial of adjunctive l-triiodothryonine J. Clin. Psychiatry 50 1989 385 388
32. R. Weizerman, and A. Weizman A use of atypical antipsychotics in mood disorders Curr. Opin. Investig. Drugs 2 2001 940 945